QUANTITATIVE HISTOLOGICAL STUDY OF THE IMMUNE RESPONSE FOR OVARIAN CANCER AND ITS PROGNOSTIC SIGNIFICANCE

QR Code

QUANTITATIVE HISTOLOGICAL STUDY OF THE IMMUNE RESPONSE FOR OVARIAN CANCER AND ITS PROGNOSTIC SIGNIFICANCE

Studied the prognostic significance of factors such as the parameters of immune responses available evaluation underlight microscopy , without costly immunohistochemical and molecular genetic methods . Identified three characteristics that predicted the outcome of ovarian cancer - the average number...

Full description

Saved in:

Bibliographic Details
Main Author:	L. V. Khalikova
Format:	Article
Language:	English
Published:	Bashkir State Medical University 2017-01-01
Series:	Креативная хирургия и онкология
Subjects:	ovarian cancer immune response histology morphometry forecast
Online Access:	https://www.surgonco.ru/jour/article/view/61
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CELLULAR IMMUNE REACTION IN A GREAT OMENTUM WITH METASTASES IN PATIENTS WITH OVARIAN CANCER
by: L. V. Khalikova, et al.
Published: (2018-08-01)

Sarcocystis spp.: histological examination and morphometry
by: V. V. Stafford
Published: (2023-12-01)

Ovarian cancer <i>in situ</i>: a case report
by: A. N. Turomsha, et al.
Published: (2024-11-01)

Histological Study on the Ovarian Development of Liparis tanakae in the Yellow Sea
by: Yunlong CHEN, et al.
Published: (2025-08-01)

Effect of mild gestational diabetes mellitus on histological, ultrastructural, and quantitative morphometric alterations of rat fetal liver
by: Sahar Ardalan Khales, et al.
Published: (2024-11-01)

THE EFFICACY OF A NEW COMPLEX DRUG FOR TREATMENT OF FOX OTODECTOSIS BASED ON THE DATA OF HISTOLOGICAL SKIN EXAMINATION
by: M. V. Arisov, et al.
Published: (2016-05-01)

FEATURES OF IMMUNE RESPONSE IN PATIENTS WITH DIFFERENT HISTOLOGICAL TYPES OF RENAL CELL CARCINOMA
by: L. М. Kurtasova, et al.
Published: (2014-07-01)

Clinical and histological features of purely stromal cell ovarian tumors
by: A. M. Beishembaev, et al.
Published: (2020-01-01)

Clinical and histological criteria for sex cord ovarian stromal tumors
by: A. М. Beishembaev, et al.
Published: (2020-09-01)

Imunotherapy opportunities in ovarian cancer
by: I. Zh. Shubina, et al.
Published: (2014-07-01)

Crosstalk between stromal, immune, and ovarian cancer cells in lipid-rich tumor microenvironment exhibits proliferative features
by: Qinsiyu Ma, et al.
Published: (2025-07-01)

THE GREATER OMENTUM IN WOMEN WITH OVARIAN CANCER
by: L. V. Khalikova
Published: (2017-02-01)

Endocrine and ovarian responses in water buffalo cows immunized against inhibin and subjected to the Ovsynch protocol
by: Abdalla Bahareldin-Ali, et al.
Published: (2015-09-01)

Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment
by: Dalia Ibrahim, et al.
Published: (2025-07-01)

Comparative Corneal Histomorphometry Between Birds of Different Species
by: Rafaela A. R. Tozetti, et al.
Published: (2025-05-01)

FAM111B Overexpression and Immune Cell Infiltration: Implications for Ovarian Cancer Immunotherapy
by: Wanying Li, et al.
Published: (2025-05-01)

Textbook of veterinary histology
Published: (1976)

Colour atlas of histology
by: Wheater, Paul R.
Published: (1985)

An atlas of histology /
by: Freeman, W. H. (William Harvey)
Published: (1968)

Identification of hypoxia-related diagnostic biomarkers and immune signatures in diminished ovarian reserve
by: Minxue Song, et al.
Published: (2025-08-01)

Prediction of a poor ovarian response in assisted reproductive technology programs in patients after surgical interventions on the ovaries
by: M. L. Dmitrieva, et al.
Published: (2024-01-01)

Differential diagnosis of ovarian neoplasm using contrast-enhanced ultrasound (clinical case)
by: N. Е. Safonova, et al.
Published: (2022-07-01)

Clinical and laboratory significance of soluble claudin-5 and VEGF in ovarian cancer
by: N. E. Kushlinskii, et al.
Published: (2025-04-01)

EPIDEMIOLOGY OF LIVER CANCER. MORBIDITY, MORTALITY, DYNAMICS OF HISTOLOGICAL STRUCTURE
by: V. M. Merabishvili, et al.
Published: (2016-02-01)

Exploring GIPC2 as a key prognostic marker in colorectal cancer linked to enhanced immune response
by: Jiaoyang Gu, et al.
Published: (2025-07-01)

Efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in the treatment of platinum resistant recurrent ovarian cancer: a retrospective observational study
by: Alexandra R. Steck, et al.
Published: (2025-08-01)

Integration of Bulk and Single-Cell RNA Sequencing to Identify RNA Modifications-Related Prognostic Signature in Ovarian Cancer
by: Wang S, et al.
Published: (2025-05-01)

Clinicopathological analysis of ovarian tumors in adolescent women under 20 years in Yazd, Iran (2011–2021): a 10-year retrospective study
by: Saadat Eslami, et al.
Published: (2025-09-01)

Histology and embryology / H. G. Q. Rowett
by: Rowett, H. G. Q. (Helen Graham Quiller)
Published: (1966)

Epigenetic Signatures in Ovarian Cancer to Determine Potential Diagnostic/Prognostic Biomarkers
by: Tuba Gunel, et al.
Published: (2024-12-01)

Proteomics in the diagnosis of ovarian cancer
by: V. E. Shevchenko, et al.
Published: (2014-07-01)

Development and Validation of Prognostic Characteristics Associated With Chromatin Remodeling‐Related Genes in Ovarian Cancer
by: Guansheng Chen, et al.
Published: (2025-02-01)

Specific Features of Ovarian Cancer Metastasis
by: R. N. Mustafin, et al.
Published: (2020-12-01)

Hydrogen Sulfide Expression May Affect Ovarian Cancer Progression and Drug Resistance
by: Zhu Q, et al.
Published: (2025-05-01)

The development of pancreatic cancer is accompanied by significant changes in the immune response in genetically predisposed mice
by: Urszula Daniluk, et al.
Published: (2025-06-01)

Immunosuppressive mechanisms and therapeutic targeting of regulatory T cells in ovarian cancer
by: Jing Li, et al.
Published: (2025-07-01)

Risk factors for sporadic ovarian cancer
by: M. M. Vysotsky, et al.
Published: (2014-08-01)

Ovarian neoplasms in pediatric gynecology (literature review)
by: L. V. Adamyan, et al.
Published: (2024-07-01)

Falloposcope for early screening of high-grade serous ovarian carcinoma
by: Anthony D. Burtman, et al.
Published: (2025-07-01)

Results of multimodality treatment with promisan incorporated into its regimen for patients with disseminated ovarian cancer
by: A. V. Zharov, et al.
Published: (2014-07-01)